[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599731":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":11,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":11,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":11,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Alexandria University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Lactase enzyme group","ACTIVE_COMPARATOR",null,[13],"Drug: lactase administration",{"label":15,"type":16,"description":11,"interventionNames":17},"Control group","PLACEBO_COMPARATOR",[18],"Other: placebo",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","lactase administration","1 drop for each 10 ml of formula milk for 14 days",[9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"placebo","10 ml milk without lactase",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Marwa M Farag, PhD","CONTACT","01288681788","d.marwa.farag@gmail.com",[36],{"facility":37,"status":38,"city":39,"state":11,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Marwa Mohamed Farag","RECRUITING","Alexandria","0325","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],29.91582,31.20176,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":33,"phoneExt":11,"email":34},"Marwa M Farag",{"type":53,"investigatorFullName":37,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Assistant professor of Pediatrics","100599731","effect-of-lactase-enzyme-supplements-on-intolerance-in-preterm-neonates-100599731",false,"NCT07088302","Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates","Effect OF Lactase Enzyme Supplements ON Protection Against Feeding Intolerance IN Preterm Neonates","Inclusion criteria will be as follows:\n\n* Preterm neonates ≤ 32 weeks gestational age.\n* Start feeding in the first 72 hours of life. 8. Exclusion criteria\n\nPatients with any of the following will be excluded:\n\n1. Parental consent lacking\u002Frefusal.\n2. Obvious major congenital abnormalities.\n3. Infants more than 72 hours of age at the time of randomization.\n4. Delayed introduction of feeding (beyond three days of life).\n5. Known galactosemia.\n6. Severe IUGR. -","ALL","3 Days","1 Month",{"count":66,"type":67},120,"ESTIMATED","INTERVENTIONAL",[70],"NA","This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.",[73,74,75],"Premature","Feeding Disorders","Lactase Deficiency, Congenital","2026-01-15",{"date":78,"type":79},"2026-01-16","ACTUAL",{"date":81,"type":79},"2025-08-30",{"date":83,"type":67},"2026-03-28",{"name":5,"class":6},1]